FY15
Assets36.96
Net Worth18.66
Total Debt7.66
RevenueAnnualised basis52.37
EBITDAAnnualised basis4.15
PATAnnualised basis0.90
EBITDA Margin (%)7.92
At a glance
Updated 2026-09-04Kwality Pharmaceuticals is an IPO with an issue size of ₹6.21 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹6.21 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets46.29₹ Cr · +61.9% vs prior year
Net Worth22.05₹ Cr · +86.1% vs prior year
FY14
Assets35.13
Net Worth17.75
Total Debt5.49
RevenueAnnualised basis59.59
EBITDAAnnualised basis3.72
PATAnnualised basis0.95
EBITDA Margin (%)6.24
FY13
Assets28.60
Net Worth11.85
Total Debt5.87
RevenueAnnualised basis61.74
EBITDAAnnualised basis3.53
PATAnnualised basis1.17
EBITDA Margin (%)5.72
31-Dec-15
Assets46.29
Net Worth22.05
Total Debt11.33
RevenueAnnualised basis53.44
EBITDAAnnualised basis4.04
PATAnnualised basis1.35
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Kwality Pharmaceuticals IPO | — | 15.00 x | — | — |
| Bio Medica IPO | — | 13.45 x | — | — |
| Goldline Pharmaceutical IPO | — | 14.56 x | — | — |
| Speciality Medicines IPO | — | 10.49 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-04.
IPO UPDATE ALERTS
Register for IPO Updates →Track Kwality Pharmaceuticals without missing an update
Register for subscription, GMP, allotment and listing notifications.